Insys Therapeutics, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases
Insys Therapeutics, Inc. reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases of $500.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-12.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases · last filed 2018-03-12
- Insys Therapeutics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, purchases for the quarter ending 2016-12-31 was $0.00.
- Insys Therapeutics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, purchases for the quarter ending 2016-09-30 was $0.00.
- Insys Therapeutics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, purchases for the quarter ending 2016-06-30 was $500.00K.
- Insys Therapeutics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, purchases for fiscal 2016 was $500.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $0.00 derived: sum of 2 quarters · filed 2018-03-12 | $500.00K derived: sum of 3 quarters · filed 2018-03-12 | $500.00K 10-K · filed 2018-03-12 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2017-11-03 | $500.00K derived: sum of 2 quarters · filed 2017-11-03 | $500.00K 10-Q · filed 2017-11-03 | |
| 2016-06-30 | $500.00K 10-Q/A · filed 2017-04-07 | $500.00K 10-Q/A · filed 2017-04-07 |